U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C5H8O
Molecular Weight 84.1164
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of Cyclopentanone

SMILES

O=C1CCCC1

InChI

InChIKey=BGTOWKSIORTVQH-UHFFFAOYSA-N
InChI=1S/C5H8O/c6-5-3-1-2-4-5/h1-4H2

HIDE SMILES / InChI

Molecular Formula C5H8O
Molecular Weight 84.1164
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Approval Year

PubMed

PubMed

TitleDatePubMed
Induction of heme oxygenase-1 expression in murine macrophages is essential for the anti-inflammatory effect of low dose 15-deoxy-Delta 12,14-prostaglandin J2.
2003-05-23
Oxidative stress causes ERK phosphorylation and cell death in cultured retinal pigment epithelium: prevention of cell death by AG126 and 15-deoxy-delta 12, 14-PGJ2.
2003-03-21
Cloning of Baeyer-Villiger monooxygenases from Comamonas, Xanthobacter and Rhodococcus using polymerase chain reaction with highly degenerate primers.
2003-03
Prostaglandin J2 metabolites inhibit aromatase activity by redox-sensitive mechanisms: potential implications for breast cancer therapy.
2003-02-20
Total synthesis of (+)-4,5-deoxyneodolabelline.
2003-02-19
Group 6 heteroatom- and non-heteroatom-stabilized carbene complexes. beta,beta'- and alpha,beta,beta'-annulation reactions of cyclic enamines.
2003-02-19
Biosynthesis of 14,15-dehydro-12-oxo-phytodienoic acid and related cyclopentenones via the phytoprostane D(1) pathway.
2003-02
The cyclopentenone prostaglandin 15-deoxy-delta(12,14)- PGJ2 attenuates the development of colon injury caused by dinitrobenzene sulphonic acid in the rat.
2003-02
Electrophilic prostaglandins and lipid aldehydes repress redox-sensitive transcription factors p53 and hypoxia-inducible factor by impairing the selenoprotein thioredoxin reductase.
2003-01-10
15-PGJ2, but not thiazolidinediones, inhibits cell growth, induces apoptosis, and causes downregulation of Stat3 in human oral SCCa cells.
2002-12-02
[Cyclopentenone prostaglandin derivatives as neuroprotective compounds].
2002-12
Prostaglandin A1 inhibits rotenone-induced apoptosis in SH-SY5Y cells.
2002-12
Role of structure and pH in cyclization of allene oxide fatty acids: implications for the reaction mechanism.
2002-12
Dual effect of oxidative stress on NF-kappakB activation in HeLa cells.
2002-11-30
Identification of a jasmonate-regulated allene oxide synthase that metabolizes 9-hydroperoxides of linoleic and linolenic acids.
2002-11-29
Tandem cyclization-cycloaddition behavior of rhodium carbenoids with carbonyl compounds: stereoselective studies on the construction of novel epoxy-bridged tetrahydropyranone frameworks.
2002-11-15
Contribution of covalent protein modification to the antiinflammatory effects of cyclopentenone prostaglandins.
2002-11
15-Deoxy-delta12,14-prostaglandin J2-induced apoptosis does not require PPARgamma in breast cancer cells.
2002-11
Synthesis and cytotoxicity of some rigid derivatives of methyl 2,5-dihydroxycinnamate.
2002-10
TX-1123: an antitumor 2-hydroxyarylidene-4-cyclopentene-1,3-dione as a protein tyrosine kinase inhibitor having low mitochondrial toxicity.
2002-10
Formation of highly reactive A-ring and J-ring isoprostane-like compounds (A4/J4-neuroprostanes) in vivo from docosahexaenoic acid.
2002-09-27
Human colorectal cancer cells efficiently conjugate the cyclopentenone prostaglandin, prostaglandin J(2), to glutathione.
2002-09-05
Translational regulation of cyclin D1 by 15-deoxy-delta(12,14)-prostaglandin J(2).
2002-09
15-deoxy-delta12,14-Prostaglandin J2 inhibits tissue factor expression in human macrophages and endothelial cells: evidence for ERK1/2 signaling pathway blockade.
2002-09
The cyclopentenone product of lipid peroxidation, 15-A(2t)-isoprostane (8-isoprostaglandin A(2)), is efficiently conjugated with glutathione by human and rat glutathione transferase A4-4.
2002-09
Cyclopentenone prostaglandins induce caspase activation and apoptosis in dendritic cells by a PPAR-gamma-independent mechanism: regulation by inflammatory and T cell-derived stimuli.
2002-09
Asymmetric cyclopentannelation: camphor-derived auxiliary.
2002-08-28
A novel approach to the synthesis of bicyclic lactones via an interrupted Nazarov reaction of gem-divinyl dihydrofurans.
2002-08-22
In vitro co-metabolism of ethanol and cyclic ketones.
2002-08-15
TiCl(4)-promoted Baylis-Hillman reactions of substituted 5-isoxazolecarboxaldehydes with cycloalkenones).
2002-08-09
Development of a new and practical route to chiral 3,4-disubstituted cyclopentanones: asymmetric alkylation and intramolecular cyclopropanation as key C-C bond-forming steps.
2002-08-09
Synthesis and anti-tumor activity of novel combretastatins: combretocyclopentenones and related analogues.
2002-08-05
Cyclopentenone prostaglandin receptors.
2002-08
Allene oxide synthases and allene oxides.
2002-08
Synthesis of 2-indanones via [4 + 1] annulation reactions of (trialkylsilyl)arylketenes.
2002-07-25
Ligands of the peroxisome proliferator-activated receptors (PPAR-gamma and PPAR-alpha) reduce myocardial infarct size.
2002-07
Enantioselective synthesis of 12-amino alkylidenecyclopentenone prostaglandins.
2002-06-28
First total synthesis of A(2) isoprostane.
2002-06-14
Effect of adjacent chiral tertiary and quaternary centers on the metal-catalyzed allylic substitution reaction.
2002-05-31
Cobalt-phosphite-catalyzed asymmetric Pauson-Khand reaction.
2002-05-17
Development of an enantioselective synthetic route to neocarzinostatin chromophore and its use for multiple radioisotopic incorporation.
2002-05-15
A proinflammatory role for the cyclopentenone prostaglandins at low micromolar concentrations: oxidative stress-induced extracellular signal-regulated kinase activation without NF-kappa B inhibition.
2002-05-15
Products of the isoprostane pathway: unique bioactive compounds and markers of lipid peroxidation.
2002-05
Fatty acid-derived signals in plants.
2002-05
The cyclopentenone prostaglandin 15-deoxy-Delta(12,14)-prostaglandin J(2) attenuates the development of acute and chronic inflammation.
2002-05
Volatile metabolites from actinomycetes.
2002-04-24
Cyclopentenone causes cell cycle arrest and represses cyclin D1 promoter activity in MCF-7 breast cancer cells.
2002-03-28
A highly enantioselective and general conjugate addition of thiols to cyclic enones with an organic catalyst.
2002-01-18
Synthesis and antituberculosis activity of cycloalkylidenehydrazide and 4-aza-1-thiaspiro[4.5]decan-3-one derivatives of imidazo[2,1-b]thiazole.
2002
Roles of prostaglandins and leukotrienes in acute inflammation caused by bacterial infection.
2001-06
Patents
Substance Class Chemical
Created
by admin
on Mon Mar 31 18:57:40 GMT 2025
Edited
by admin
on Mon Mar 31 18:57:40 GMT 2025
Record UNII
220W81TN3S
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
Cyclopentanone
FHFI   HSDB   MI  
Systematic Name English
FEMA NO. 3910
Preferred Name English
NSC-4122
Code English
ADIPIN KETON
Common Name English
CYCLOPENTANONE [HSDB]
Common Name English
CYCLOPENTANONE [MI]
Common Name English
ADIPIC KETONE
Common Name English
KETOPENTAMETHYLENE
Common Name English
DUMASIN
Common Name English
KETOCYCLOPENTANE
Systematic Name English
CYCLOPENTANONE [FHFI]
Common Name English
Classification Tree Code System Code
JECFA EVALUATION CYCLOPENTANONE
Created by admin on Mon Mar 31 18:57:40 GMT 2025 , Edited by admin on Mon Mar 31 18:57:40 GMT 2025
Code System Code Type Description
DAILYMED
220W81TN3S
Created by admin on Mon Mar 31 18:57:40 GMT 2025 , Edited by admin on Mon Mar 31 18:57:40 GMT 2025
PRIMARY
WIKIPEDIA
Cyclopentanone
Created by admin on Mon Mar 31 18:57:40 GMT 2025 , Edited by admin on Mon Mar 31 18:57:40 GMT 2025
PRIMARY
PUBCHEM
8452
Created by admin on Mon Mar 31 18:57:40 GMT 2025 , Edited by admin on Mon Mar 31 18:57:40 GMT 2025
PRIMARY
JECFA MONOGRAPH
1033
Created by admin on Mon Mar 31 18:57:40 GMT 2025 , Edited by admin on Mon Mar 31 18:57:40 GMT 2025
PRIMARY
MESH
C007201
Created by admin on Mon Mar 31 18:57:40 GMT 2025 , Edited by admin on Mon Mar 31 18:57:40 GMT 2025
PRIMARY
HSDB
2822
Created by admin on Mon Mar 31 18:57:40 GMT 2025 , Edited by admin on Mon Mar 31 18:57:40 GMT 2025
PRIMARY
MERCK INDEX
m4008
Created by admin on Mon Mar 31 18:57:40 GMT 2025 , Edited by admin on Mon Mar 31 18:57:40 GMT 2025
PRIMARY Merck Index
RXCUI
2557363
Created by admin on Mon Mar 31 18:57:40 GMT 2025 , Edited by admin on Mon Mar 31 18:57:40 GMT 2025
PRIMARY
CAS
120-92-3
Created by admin on Mon Mar 31 18:57:40 GMT 2025 , Edited by admin on Mon Mar 31 18:57:40 GMT 2025
PRIMARY
NSC
4122
Created by admin on Mon Mar 31 18:57:40 GMT 2025 , Edited by admin on Mon Mar 31 18:57:40 GMT 2025
PRIMARY
EPA CompTox
DTXSID3029154
Created by admin on Mon Mar 31 18:57:40 GMT 2025 , Edited by admin on Mon Mar 31 18:57:40 GMT 2025
PRIMARY
ECHA (EC/EINECS)
204-435-9
Created by admin on Mon Mar 31 18:57:40 GMT 2025 , Edited by admin on Mon Mar 31 18:57:40 GMT 2025
PRIMARY
FDA UNII
220W81TN3S
Created by admin on Mon Mar 31 18:57:40 GMT 2025 , Edited by admin on Mon Mar 31 18:57:40 GMT 2025
PRIMARY
CHEBI
16486
Created by admin on Mon Mar 31 18:57:40 GMT 2025 , Edited by admin on Mon Mar 31 18:57:40 GMT 2025
PRIMARY